Tetrabenazine 12.5 MG Oral Tablet

1 INDICATIONS AND USAGE Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington’s disease. Tetrabenazine is a vesicular monoamine transporter 2 (VMAT) inhibitor indicated for the treatment of chorea associated with Huntington’s disease. (1)

dr. reddys laboratories inc

FDA Reported Adverse Reactions
`[1] dyspnoea` `[2] fatigue` `[3] nausea` `[4] pneumonia` `[5] diarrhoea` `[6] headache` `[7] cough` `[8] death` `[9] dizziness` `[10] off label use`

4 years ago

ROUND YELLOW 394

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

TETRABENAZINE tablets are available in the following strengths and packages: The 12.5 mg

TETRABENAZINE tablets are light yellow to yellow, round flat-faced beveled edge uncoated tablets, plain on one side and debossed with “394” on other side. Bottles of 112’s NDC 43598-394-67 Bottles of 500’s NDC 43598-394-05 The 25 mg

TETRABENAZINE tablets are light yellow to yellow, round flat-faced beveled edge uncoated tablets, breakline on one side and debossed with “395” on other side. Bottles of 112’s NDC 43598-395-67 Bottles of 500’s NDC 43598-395-05 16.2 Storage Store at 20ºC to 25ºC (68ºF to 77ºF); [See USP Controlled Room Temperature].

More pills like ROUND 394

Related Pills

Tetrabenazine 25 MG Oral Tablet

dr. reddys laboratories inc

Loxapine 5 MG Oral Capsule

lannett company, inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site